These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 28240184)

  • 1. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-to-Lead Medicinal Chemistry Publications in 2020.
    de Esch IJP; Erlanson DA; Jahnke W; Johnson CN; Walsh L
    J Med Chem; 2022 Jan; 65(1):84-99. PubMed ID: 34928151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Space of DNA-Encoded Libraries.
    Franzini RM; Randolph C
    J Med Chem; 2016 Jul; 59(14):6629-44. PubMed ID: 26914744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.
    Keserű GM; Erlanson DA; Ferenczy GG; Hann MM; Murray CW; Pickett SD
    J Med Chem; 2016 Sep; 59(18):8189-206. PubMed ID: 27124799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based drug discovery and its application to challenging drug targets.
    Price AJ; Howard S; Cons BD
    Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based drug design.
    Feyfant E; Cross JB; Paris K; Tsao DH
    Methods Mol Biol; 2011; 685():241-52. PubMed ID: 20981527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based drug discovery using rational design.
    Jhoti H
    Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.
    Galdeano C; Ciulli A
    Future Med Chem; 2016 Sep; 8(13):1655-80. PubMed ID: 27193077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From small to powerful: the fragments universe and its "chem-appeal".
    Sancineto L; Massari S; Iraci N; Tabarrini O
    Curr Med Chem; 2013; 20(11):1355-81. PubMed ID: 23410157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
    Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
    Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rise of fragment-based drug discovery.
    Murray CW; Rees DC
    Nat Chem; 2009 Jun; 1(3):187-92. PubMed ID: 21378847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in fragment-based drug discovery platforms.
    Orita M; Warizaya M; Amano Y; Ohno K; Niimi T
    Expert Opin Drug Discov; 2009 Nov; 4(11):1125-44. PubMed ID: 23480433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based drug discovery-the importance of high-quality molecule libraries.
    Bon M; Bilsland A; Bower J; McAulay K
    Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal chemistry inspired fragment-based drug discovery.
    Lanter J; Zhang X; Sui Z
    Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.